Who is susceptible to myeloma? Can myeloma be cured completely?

Updated on healthy 2024-07-05
15 answers
  1. Anonymous users2024-02-12

    Chemists and people who work in factories are prone to myeloma, myeloma can be completely ** and can be done by going to the hospital for surgery**.

  2. Anonymous users2024-02-11

    Myeloma, also known as plasmacytoma, is a malignant plasmacytoproliferative disorder.

    It is more likely to occur in middle-aged and elderly people between the ages of 40 and 60.

    It cannot be **, but it can be controlled for a long time, so that the patient can get the purpose of long-term survival. The median survival of patients can be extended to years, and the survival time can be extended to more than 5 years, or even more than 10 years, with the application of new drugs and stem cell transplantation.

  3. Anonymous users2024-02-10

    Myeloma refers to a malignant disease in which the hematopoietic tissues of the bone marrow and peripheral blood have abnormal plasma cell proliferation. After abnormal proliferation of plasma cells, they can invade hematopoiesis, bone marrow, blood, and even organ tissues.

    For patients with bone marrow cancer, if they find their symptoms at the early stage and do not actively cooperate with the doctor, their survival time will only be a few months. There are many factors that affect the survival expectation of bone marrow cancer patients, such as personal psychological factors, physical state, mental state and positive attitude towards cancer.

    Expansion of Myeloma** Methods.

    1. Chemotherapy: Chemotherapy is the most basic method for myeloma. Common chemotherapy drugs include bortezomib, thalidomide, and cyclophosphamide.

    2. Hematopoietic stem cell transplantation: For patients under the age of 65, if the effect before chemotherapy is good, autologous hematopoietic stem cell transplantation will be performed as consolidation** to improve the survival rate of patients.

    3. Maintenance: Maintenance** drugs are commonly used in ranalidomide, thalidomide, etc.

  4. Anonymous users2024-02-09

    Myeloma, also known as plasmacytoma, is a malignant tumor. It can't**, but it can be controlled for a long time and prolong the patient's life. Myeloma can be effectively controlled if the condition is good.

    If the condition is poor, death usually occurs within 1 year. As for how much life you can have, as long as you start to see the situation after **.

  5. Anonymous users2024-02-08

    Patients with multiple myeloma are currently unable to**. Multiple myeloma is a heterogeneous disease, and different patients have very different responses, complications, and longevity. The length of life varies greatly, from a few months for the shortest to more than 10 years for the elderly.

    The key lies in the best methods adopted by patients, biological technology can greatly improve the quality of life of patients, prolong the life of patients, and among many patients using biological **, there are also cases of tumor disappearance or long-term survival with tumors.

  6. Anonymous users2024-02-07

    The key lies in the patient's condition and the patient's choice of method. Choosing a regular hospital, choosing a professional doctor, and a suitable method can greatly extend the life cycle and life of the patient. Therefore, everyone must remember not to give up on themselves, and there is still a chance and hope of survival in time.

    Generally speaking, if it is allowed to develop, the patient's life expectancy is mostly between 6-12 months, if it is timely, and actively do a good job of daily care, the patient's survival time is often more than ten years, for advanced patients, whether the method is appropriate is very critical, so we must be cautious when we are in the first place, consult a few hospitals, and refer to the opinions of experts.

  7. Anonymous users2024-02-06

    Yes, but the probability is relatively small. It doesn't look at the individual's physique, some people have a longer time, and some people don't have so much time.

  8. Anonymous users2024-02-05

    The rate of hematological malignant tumors is not high, depending on the development of the disease, the early and middle life expectancy is longer, and the life expectancy is more than ten years, and the late life span may only be a few months.

  9. Anonymous users2024-02-04

    Initial patients can **, but it is difficult to say if it is more serious. In the later stages, patients have only a few months to live.

  10. Anonymous users2024-02-03

    First of all, the disease of bone marrow cancer is a particularly serious disease in daily diseases, for the disease of bone marrow cancer so far, the cause of the disease is not very clear, to achieve early detection, early examination and early **, so what is a good way for early prevention and care, in fact, if myeloma can get split silver in a timely and effective manner, the hope is still very large, which is mainly to match with family members and doctors.

    Secondly, the diseases of bone marrow cancer**: 1. Radiation**: Myeloma is moderately sensitive to radiation, and the radiation dose of palliative and sexual is different.

    2. Chemotherapy: chemotherapy should be used for patients with extensive lesions. Generally, levophenylalanine chlormustard or cyclophosphamide is mostly used, as well as methylbenzylhydrazine, dichlorohexanesulfitoride and vincristine.

    Finally, surgery**, if there is spinal cord or nerve root compression, decompression should be performed along with chemotherapy. The prognosis of surgery is poor, and most people usually die within 1 year. It can prolong life after synthesis**.

  11. Anonymous users2024-02-02

    Multiple Myeloma Multiple myeloma is a plasma cell malignancy that invades the bone marrow. Some white blood cells in the blood produce plasma cells after leaving the bone marrow, and different types of plasma cells produce different antibodies to deal with the invasion of different foreign substances, but when plasma cells overgrow for some reason, not only the number increases, but also the same type becomes myeloma cells. These cells sometimes accumulate on a single local bone to form plasmacytoma, and sometimes they invade multiple bones to form multiple cancerous masses, which is called multiple myeloma .

    Myeloma destroys bones and causes pain or fractures; or let calcium stay in the bloodstream, resulting in loss of appetite, tiredness, muscle weakness, and even confusion, or due to weakened immunity, serious infections occur; or cause anemia, renal dysfunction, etc. The incidence of multiple myeloma is about 3 100,000, with the majority (60) occurring in males and 98 occurring after the age of 40. ** The exact cause of the disease is unknown, and it may be related to genetics; Genetic mutations caused by invasion of chromosomes 8, 11 or 14, or exposure to toxic chemicals or intense radiation are also some factors.

    Skeletal invasion: Occurs in the skull, vertebrae, ribs, pelvis, and proximal long bones. 2.

    Elevated blood calcium: 1 3 patients have elevated blood calcium, vomiting, loss of appetite and so on. 3.

    Protein abnormalities: M-type proteins are produced, which also reduce the production of immunoglobulins, resulting in a decrease in the body's defenses. 4.

    Decreased kidney function: About half of patients will develop kidney disease. 5.

    Neurological impairment: About 15 patients have spinal nerve compression, and peripheral nerves can also be damaged by plasma cell invasion. Diagnosis 1

    Symptoms: fatigue, weakness, weight loss, bone pain, cold intolerance, nervous disorders, bleeding tendency, etc. 2.

    Symptoms: Occasionally, hepatosplenomegaly, lymphomaly, and most often neuropathy. 3.

    Tests: anemia, thrombocytopenia, neutropenia. b Pathological examination of lesions, masses or lymph nodes of bone marrow or bone.

    c Serum protein assay, there will be an increase in M protein, an increase in IgG d Skeletography, bone densitometry, magnetic resonance ** · Orthopedic Assisted Surgery · Radiotherapy Chemicals**.

  12. Anonymous users2024-02-01

    Osteoid osteoma is a type of tumor that grows on the bone. Osteoid osteoma is a benign tumor that rarely undergoes malignant transformation or even metastasis. Osteoid osteoma often occurs in the diaphysis of long bones, and is manifested in the bone and cortical areas of the bone with oval tumor nests, and the surrounding bone shows obvious hardening, forming hardened bone, which is manifested like an eye.

    Osteoid osteoma occurs mainly at the cortical end of long bones, and can also produce multiple manifestations of osteoid osteoma, with nests and surrounding osteosclerosis in long bones, cortex, or metaphysis. Osteoid osteoma generally requires surgery as soon as it is found**, which is manifested by curettage or resection of the local tumor segment, bone grafting, reduction and internal fixation**. After treatment, the probability of osteoid osteoma is generally small, but the osteoid osteoma that is easy to become malignant is very malignant, and very few can metastasize.

  13. Anonymous users2024-01-31

    Bio immunity** is recommended!

  14. Anonymous users2024-01-30

    Of course, multiple myeloma should be **, not to mention that patients with renal insufficiency should be more active**; The current ** is definitely chemotherapy; Except for chemotherapy, there is no drug that has the best effect on myeloma.

    Chief Physician of Beijing Chaoyang Hospital-Hematological Oncology-Chen Wenming.

  15. Anonymous users2024-01-29

    Hello! It has been described as more consistent with myeloma lesions, but further testing is needed to confirm the diagnosis.

    Myeloma is a disease of old age that can be buried.

    Our center is mainly engaged in the diagnosis and treatment and research of myeloma, and practice has proved that the current efficacy has reached the international level, and if conditions permit, you can go to our hospital for further diagnosis and treatment.

    Dr. Qiu Lugui solemnly mentioned that the patient could not be seen face-to-face and could not fully understand the condition, the above suggestions are for reference only, and the specific diagnosis and treatment must be buried in the hospital under the guidance of the doctor! )

Related questions
10 answers2024-07-05

There is not much comparison, but in terms of survival time, myeloma survival time is shorter. >>>More

16 answers2024-07-05

Bone marrow cancer is generally not inherited. Modern medicine believes that different tumors may have different modes of genetic transmission, and the role of genetic factors in most tumorigenesis is the susceptibility or predisposition to carcinogenic factors. Genetic susceptibility to cancer refers to the predisposition of individuals in the same living conditions to develop cancer. >>>More

14 answers2024-07-05

There is a genetic predisposition to any disease, but the chance of being actually inherited is very small, so it is better to worry less. Less anxiety and a happy mindset are the magic weapons to prevent cancer!

10 answers2024-07-05

Multiple myeloma generally survives for 3 to 4 years, sometimes more than 10 years, and serious complications can be life-threatening if severe kidney damage is present. >>>More

14 answers2024-07-05

1. None, anti-tumor chemotherapy is still the mainstay. (1) M2 regimen: carachlorethamine 20mg m2 intravenous injection, cyclophosphamide 400mg m2 intravenous injection on day 1, day 1; chlorambucil phenylpropionate 4 mg m2 daily orally on day 1 7 and 10 mg m2 orally daily on day 1 4; Prednone 40 mg m2 orally daily on days 1 7 and 20 mg orally daily on days 8 to 14. >>>More